SARASOTA, Fla., March 8, 2021 /PRNewswire/ — INVO Bioscience, Inc. (NASDAQ: INVO), a medical unit firm targeted on commercializing the world’s only in vivo Intravaginal
Tag: Commercialization
VolitionRx Delivers a Business Update and Appoints Vital Officers to Drive Commercialization Efforts
AUSTIN, Texas, Feb. 2, 2021 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) these days supplied a company update and introduced the appointment of a